Relay Therapeutics Inc
NASDAQ:RLAY
Cash Flow Statement
Cash Flow Statement
Relay Therapeutics Inc
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||
| Net Income |
(75)
|
(86)
|
(95)
|
(112)
|
(52)
|
(70)
|
(236)
|
(261)
|
(364)
|
(384)
|
(267)
|
(290)
|
(291)
|
(323)
|
(344)
|
(326)
|
(342)
|
(329)
|
(323)
|
(345)
|
(338)
|
(333)
|
(312)
|
(298)
|
|
| Depreciation & Amortization |
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
6
|
6
|
5
|
5
|
5
|
4
|
|
| Stock-Based Compensation |
4
|
5
|
8
|
19
|
32
|
40
|
52
|
53
|
48
|
52
|
51
|
53
|
56
|
64
|
72
|
81
|
86
|
92
|
95
|
96
|
94
|
86
|
74
|
67
|
|
| Other Non-Cash Items |
2
|
2
|
6
|
18
|
32
|
40
|
188
|
191
|
188
|
188
|
52
|
55
|
46
|
55
|
58
|
58
|
69
|
72
|
65
|
67
|
69
|
65
|
68
|
64
|
|
| Change in Working Capital |
4
|
3
|
3
|
0
|
(85)
|
(8)
|
4
|
(4)
|
97
|
22
|
12
|
20
|
11
|
16
|
23
|
(5)
|
(32)
|
(32)
|
(29)
|
(7)
|
15
|
(8)
|
(23)
|
(19)
|
|
| Cash from Operating Activities |
(66)
N/A
|
(78)
-17%
|
(83)
-7%
|
(90)
-8%
|
(102)
-14%
|
(34)
+67%
|
(41)
-22%
|
(70)
-71%
|
(74)
-6%
|
(170)
-129%
|
(199)
-17%
|
(212)
-6%
|
(229)
-8%
|
(247)
-8%
|
(259)
-5%
|
(268)
-4%
|
(300)
-12%
|
(284)
+6%
|
(281)
+1%
|
(280)
+0%
|
(249)
+11%
|
(272)
-9%
|
(261)
+4%
|
(248)
+5%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||
| Capital Expenditures |
(8)
|
(6)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
(3)
|
(3)
|
(6)
|
(7)
|
(8)
|
(9)
|
(8)
|
(8)
|
(6)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
|
| Other Items |
(311)
|
(260)
|
185
|
196
|
84
|
(201)
|
(263)
|
(261)
|
(476)
|
(352)
|
(334)
|
(327)
|
(180)
|
7
|
15
|
57
|
262
|
197
|
190
|
(8)
|
(39)
|
(9)
|
21
|
187
|
|
| Cash from Investing Activities |
(319)
N/A
|
(266)
+17%
|
181
N/A
|
194
+7%
|
82
-58%
|
(202)
N/A
|
(264)
-30%
|
(263)
+0%
|
(480)
-82%
|
(358)
+25%
|
(341)
+5%
|
(335)
+2%
|
(189)
+44%
|
(1)
+99%
|
7
N/A
|
51
+646%
|
258
+405%
|
193
-25%
|
187
-3%
|
(10)
N/A
|
(41)
-295%
|
(9)
+78%
|
20
N/A
|
186
+811%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||
| Net Issuance of Common Stock |
6
|
1
|
1
|
429
|
429
|
431
|
431
|
4
|
388
|
387
|
388
|
673
|
290
|
290
|
290
|
14
|
35
|
82
|
82
|
291
|
270
|
0
|
220
|
1
|
|
| Other |
0
|
0
|
(0)
|
(3)
|
(3)
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
6
N/A
|
1
-84%
|
0
-84%
|
426
+284 053%
|
427
+0%
|
428
+0%
|
429
+0%
|
4
-99%
|
388
+9 274%
|
387
0%
|
388
+0%
|
673
+73%
|
290
-57%
|
290
+0%
|
290
+0%
|
14
-95%
|
35
+148%
|
82
+137%
|
82
-1%
|
291
+256%
|
270
-7%
|
221
-18%
|
220
0%
|
1
-99%
|
|
| Change in Cash | |||||||||||||||||||||||||
| Net Change in Cash |
(380)
N/A
|
(342)
+10%
|
98
N/A
|
530
+443%
|
406
-23%
|
192
-53%
|
125
-35%
|
(329)
N/A
|
(166)
+50%
|
(142)
+15%
|
(152)
-8%
|
126
N/A
|
(128)
N/A
|
42
N/A
|
38
-8%
|
(203)
N/A
|
(8)
+96%
|
(8)
-4%
|
(12)
-42%
|
0
N/A
|
(20)
N/A
|
(60)
-199%
|
(21)
+66%
|
(61)
-194%
|
|
| Free Cash Flow | |||||||||||||||||||||||||
| Free Cash Flow |
(74)
N/A
|
(84)
-13%
|
(88)
-5%
|
(92)
-5%
|
(104)
-13%
|
(35)
+67%
|
(42)
-21%
|
(73)
-72%
|
(78)
-7%
|
(176)
-126%
|
(206)
-17%
|
(220)
-6%
|
(239)
-9%
|
(256)
-7%
|
(267)
-4%
|
(275)
-3%
|
(304)
-11%
|
(287)
+6%
|
(283)
+1%
|
(283)
+0%
|
(251)
+11%
|
(273)
-9%
|
(262)
+4%
|
(249)
+5%
|
|